Cornelius Roemer Profile picture
Aug 15, 2021 5 tweets 3 min read Read on X
Die Ankündigung der 3G-Regel durch die MPK (Dienstag, 10. August) zeigt sich direkt in der Erstimpfrate.
Der Wochenschnitt sinkt nicht mehr.
Am Donnerstag wurden bereits 13% mehr geimpft als die Woche zuvor.
Davor war der Rückgang etwa 20% pro Woche. 1/4
Die Grafik oben zeigt das Verhältnis der Summe der Erstimpfungen der letzten 7 Tage zu den 7 Tagen zuvor.
Hier ist die jeweilige Tagesveränderung, jeweils Tag geteilt durch Tag der Vorwoche. 2/4
1 Tag nach der MPK wurden zum ersten Mal seit Monaten innerhalb einer Woche wieder mehr Menschen erstgeimpft als am Vortag (+1%). 3/4
Wenn die jetzige Erstimpfrate konstant bleibt, dauert es noch 60 Wochen bis jede in Deutschland erstgeimpft ist.
Die Rate ist also viel zu niedrig und müsste mindestens verdoppelt werden um eine große Belastung der Krankenhäuser in den nächsten Monaten zu vermeiden. 4/4
Und jetzt stelle man sich mal vor, wie das ganze abgehen würde, wenn Bundes- und Landesregierungen ein paar Cent in die Hand nähmen, damit man wie beim Blutspenden nach der Impfung eine kleine Mahlzeit bekäme.
@janoschdahmen @Karl_Lauterbach gibt's da Überlegungen? 5/4

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Cornelius Roemer

Cornelius Roemer Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @CorneliusRoemer

Aug 21, 2023
Here are counts of BA.2.86 and overall sequence submissions to GISAID
Note that the English sample included in week 2023-08-07 likely got expedited, so it may be best to exclude from this analysis. 1/ Image
In my very rough reading, there's not enough data yet to pin down growth advantage. It could be small or non-existent, or it could be sizeable, e.g. doubling every week.
Bear in mind that due to constant antigenic drift, there are always lineages with decent growth advantage. 2/
To really have an impact, BA.2.86 would have to become dominant, outgrowing even the fittest lineages around, e.g. HK.3 (EG.5.1 with S:L455F) or FL.1.5.1 (456L, 478R) which themselves are doubling in share about every two weeks. 3/
Read 14 tweets
Aug 11, 2023
EG.5 (and EG.5.1) has recently got attention due to being highlighted by @UKHSA and @WHO.
EG.5, which is an alias for XBB.1.9.2.5, is a sublineage of XBB characterized in particular by Spike RBD mutation F456L. 1/
EG.5 is one of the fastest growing XBB sublineages, particularly common in China where it appears to be dominant.
As EG.5 has only one RBD difference compared to the upcoming vaccine strain XBB.1.5 vaccine protection is expected to be good. 2/
While the name EG.5 may sound very different from XBB, it is important to know that this is just due to naming - EG.5 is the short form of XBB.1.9.2.5. 3/
Read 8 tweets
Apr 10, 2023
It appears that China has stopped uploading SARS-CoV-2 sequences to GISAID and now shares via its own version of Genbank: Genbase
github.com/yatisht/usher/…
I don't yet fully understand the terms under which China shares the sequences - I assume (and hope_ they are just as open as Genbank.
In that case this is a great development towards having as much SARS-CoV-2 data being free of usage restrictions as possible.
GISAID should still be able to integrate the data in their platform (unless the license prohibits it, if it's Genbank-like then GISAID can pull the data as they've done with Genbank-only published sequences).
Read 6 tweets
Nov 28, 2022
I'm seeing quite a bit of discussion about the potential impact of a big wave in mainland China on variant evolution.
I do not think a big wave in mainland China would have major consequences outside of China. 1/
While China is a big country, it has less than 20% of the global population. The rate at which new variants evolve would only increase slightly as a result of fractionally more infections worldwide. 2/
We have by now seen multiple second generation BA.2 variants evolve independently: BA.4/5 in Southern Africa, BA.2.75 in South Asia, BA.2.3.20 in the Philippines, BS.1 in South East Asia. 3/
Read 9 tweets
Oct 14, 2022
For straightforward problems, @github Copilot really rocks.
Yes, as a Python dev, I could code this up myself in less than a minute
But why spend mental energy on this if it can be auto-generated?
As a beginner, this could have easily taken me a few minutes. Now it's just seconds
And the only unnatural about this example is that I deleted the output generated by copilot before recording.
Everything else is exactly as it was when I did it.
Nothing contrived, very natural usage pattern.
It's hard to think of a better way of solving this problem.
Copilot chose a very pythonic solution.
There's a good chance handwritten solutions by many developers would be less idiomatic and more confusing.
Read 6 tweets
Oct 13, 2022
BQ.1* and XBB have different geographic foci
BQ.1* is mostly in Africa, Europe and North America
XBB in South (East) Asia
3 countries with similar levels worth watching for comparison and potential co-circulation are:
- Japan
- Australia
- South Korea
cov-spectrum.org/explore/World/… 1/ ImageImageImage
BQ.1.1 and XBB have quite a lot of spike differences and seem to have similar growth advantages - this makes them candidates for co-circulation.
We may only be able to know once we see how the variants do in countries that had a wave with the other one. 2/
Here are the mutations that only occur in one of the two variants:
XBB only: S:V83A, S:Y144-, S:H146Q, S:Q183E, S:V213E, S:G339H, S:R346T, S:L368I, S:V445P, S:G446S, S:F486S, S:F490
BQ.1.1 only:
S:H69-, S:V70-, S:V213G, S:G339D, S:K444T, S:L452R, S:F486V 3/
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(